FDA Hearing Backs Psychedelic Therapy Potential, Stresses Safety
The U.S. Food and Drug Administration held a public hearing on Monday to gather feedback on the potential future use of psychedelic drugs in supervised therapeutic settings, marking a significant step in the federal g...